Showing 6 articles for
GW Pharma
Study Finds CBD Drug Epidiolex Reduces Seizures by 42%
High daily doses of CBD significantly reduced seizures in patients with Lennox-Gastaut syndrome.
Cannabis Investing: Does Revenue Even Matter?
Revenue generation isn't always rewarded by the stock market. Here's how to read revenue figures, and why you should dive deeper before investing.
South Dakota House Blunts GW Pharma Bill
The bill would have given GW a temporary monopoly on CBD in the state. New language moves all forms of CBD to Schedule IV.
GW Pharma Responds: ‘Not Creating a Monopoly’
The pharmaceutical developer says it's pioneering markets, not elbowing out competitors.
Leafly Exclusive: GW Pharma is Moving CBD Bills on the Down Low
The proposed state measures would give the British pharma company's new drug--but not other CBD products--legal status.
The Shake: Denver Has Growhouse Brokers, and Miami Cops Bust Man with Majestic Half-Beard
Legalization advocates are at the White House today, a Utah study shows further potential for cannabis epilepsy treatment, and seriously, this guy's beard.